Aller au contenu principal
2026 conference-abstract

Abstract 1930: Unveiling ecDNA spatial organization and epigenetic landscapes through long-read multi-omic sequencing and high-content microscopy.

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Oncogene amplification is one of the most common genetic alterations in cancer, playing a central role in tumorigenesis. A major mechanism of oncogene amplification is extrachromosomal DNA (ecDNA), which is present in nearly 20% of cancer patients and found across half of all cancer types. Patients with ecDNA-positive tumors have significantly shorter survival compared to those without ecDNA. Despite its prevalence and strong association with poor treatment outcomes, there is no approved treatment targeting ecDNA-positive cancers. Developing such treatments requires identifying unique and actionable features of ecDNA. Two unique features of ecDNA warrant special attention because they are seemingly paradoxical. On one hand, proliferation of cancer cells depends on high-level oncogene expression from ecDNA. On the other hand, ecDNA molecules preferentially cluster at the nuclear periphery, a region typically associated with transcriptional repression. Why would cancer cells position most of their ecDNA at the nuclear periphery? What molecular mechanisms control this localization, and what are its functional consequences? These are longstanding questions in the field that have remained unanswered largely due to the lack of experimental approaches capable of deciphering the molecular heterogeneity of ecDNA and linking its spatial organization to oncogene expression. To fill the technical gap and answer these fundamental ecDNA biology questions, we developed DINO-seq, a long-read single-molecule sequencing technology that enables simultaneous profiling protein binding, DNA accessibility and CpG methylation on individual ecDNA molecules. Using DINO-seq, we discovered that ecDNA carries a bivalent epigenetic landscape—coexisting active and repressive epigenetic marks—that is distinct from chromosomal DNA and enables ecDNA to remain transcriptionally active even at the nuclear periphery. Combining a CRISPR screen with high-content microscopy, we further identified molecular anchors that tether ecDNA to the nuclear periphery. Functionally, we show that peripheral ecDNA localization alters replication timing, promotes ecDNA hub formation, and enhances RNA transcription and export. Together, these findings reveal that ecDNA possesses unique spatial and epigenetic properties that distinguish it from chromosomal DNA and represent potential vulnerabilities that could be exploited to target ecDNA-positive cancers. Citation Format: Yanbo Wang, Xiaowei Yan, Natasha E. Weiser, Shu Zhang, Ivy Tsz-Lo Wong, Yung-Hsin Huang, Rui Li, Nicolas Altemose, Paul S. Mischel, Howard Y. Chang. Unveiling ecDNA spatial organization and epigenetic landscapes through long-read multi-omic sequencing and high-content microscopy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1930.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Abstract 1930: Unveiling ecDNA spatial organization and epigenetic landscapes through long-read multi-omic sequencing and high-content microscopy.
Date Crossref
03/04/2026
Éditeur
American Association for Cancer Research (AACR)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Stanford University pays non établi dans la notice
    Université ou école supérieure
  • Stanford Medicine pays non établi dans la notice
    Établissement de santé

Stanford University et Stanford Medicine.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Cancer Genomics and DiagnosticsEpigenetics and DNA MethylationSingle-cell and spatial transcriptomics

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.